The invention is directed towards stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid and its hemisulfate salt as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
本发明涉及 5,10-亚甲基-(6R)-四氢叶酸及其半
硫酸盐的稳定制剂以及药物组合物及其在治疗中的用途,最好是化疗。